Skip to content
value.today

Alpfa Medical, Inc.

Formerly Squirrel Corporation

Total raised
$80 M
1 round on record
Latest round
$80 M
Sep 2026
First round on record
Sep 2026
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Alpfa Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2026$80 MNo. 1$50 to $250 million

Alpfa Medical, Inc.: Raise no. 1, Sep 2026

Investors in this round

71 investors had bought by the notice of Sep 28, 2026: 71 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$80 M of $100 M offered; $20 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Offering of preferred stock and the underlying common stock issuable upon conversion of the preferred stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allan Zingeler · Executive Officer, Director
  • Michael Wiley · Executive Officer, Director
  • Rupa Patel · Executive Officer
  • Andrew ElBardissi · Director
  • David Bonita · Director
  • Michael Hurley · Director
  • Michael Kramer · Director
  • Raju Viswanathan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series B-1 + Series B-2 Preferred Stock and the Common Stock issuable upon conversion thereof. Includes $30,268,087in value of cancelled convertible instruments. The remaining $19,999,978 of the total offering amount reserved for future milestone closings”

Signed by Allan Zingeler, Chief Executive Officer. Newest notice filed Sep 28, 2026. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Alpfa Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2026).

    SEC Form D · Sep 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Sep 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Alpfa Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Alpfa Medical, Inc.
NameRoleNamed in
Allan ZingelerExecutive officerSep 2026
Michael WileyExecutive officerSep 2026
Rupa PatelExecutive officerSep 2026
Allan ZingelerDirectorSep 2026
Andrew ElBardissiDirectorSep 2026
David BonitaDirectorSep 2026
Michael HurleyDirectorSep 2026
Michael KramerDirectorSep 2026
Michael WileyDirectorSep 2026
Raju ViswanathanDirectorSep 2026